PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

alosetron vs aprepitant

Side-by-side comparison of alosetron and aprepitant Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
alosetron 5-HT3 Antagonist (IBS-D)
aprepitant NK1 Receptor Antagonist (Antiemetic)
Type
alosetron Prescription
aprepitant Prescription
Summary
alosetron

Alosetron (Lotronex) is a medicine for women with severe diarrhea-predominant irritable bowel syndrome (IBS). It helps to reduce diarrhea and stomach pain.

aprepitant

Aprepitant (Emend) is a medicine that helps prevent nausea and vomiting. It belongs to a class of drugs called NK1 receptor antagonists.

What It Treats
alosetron

Alosetron is used to treat severe diarrhea-predominant irritable bowel syndrome (IBS) in women. It is for women whose IBS symptoms have lasted for 6 months or longer. You should have already ruled out other possible causes of your symptoms. This medicine is only for you if other treatments have not worked well enough.

aprepitant

Aprepitant is used to prevent nausea and vomiting caused by chemotherapy. It can be used for both strong and moderate chemotherapy treatments. It is also used to prevent nausea and vomiting after surgery in adults.

How It Works
alosetron

Alosetron blocks a substance called serotonin in your gut. Serotonin can speed up bowel movements. By blocking serotonin, alosetron slows down your bowel and reduces diarrhea.

aprepitant

Aprepitant blocks a substance in your body called substance P. Substance P can trigger nausea and vomiting. By blocking it, aprepitant helps reduce these side effects.

Common Side Effects
alosetron
  • Constipation
  • Abdominal discomfort and pain
  • Nausea
  • Gastrointestinal discomfort and pain
aprepitant
  • Tiredness
  • Diarrhea
  • Weakness
  • Upset stomach
  • Stomach pain
FAERS Reports
alosetron
  • Medicine not working 11
  • Diarrhea 10
  • Feeling sick to your stomach 8
  • Using the medicine for something it's not approved for 7
  • Stomach pain 6
aprepitant
  • Feeling sick to your stomach 2,147
  • Tiredness 1,769
  • Fever 1,589
  • Diarrhea 1,543
  • Difficulty breathing 1,508
Serious Warnings
alosetron

Alosetron can cause serious gut problems, like ischemic colitis (reduced blood flow to the bowel) and severe constipation. These problems can lead to hospitalization, surgery, or even death. Stop taking alosetron right away if you get constipated or have symptoms of ischemic colitis, like bloody diarrhea or bad stomach pain. Call your doctor immediately.

aprepitant

Aprepitant can interact with other medicines. It can affect how well warfarin (a blood thinner) and hormonal birth control work. If you take warfarin, your doctor will check your blood. If you use hormonal birth control, use a backup method while taking aprepitant and for 28 days after your last dose.

Pregnancy
alosetron

It is not known if alosetron can harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if alosetron passes into breast milk. Talk to your doctor about the best way to feed your baby if you take alosetron.

aprepitant

There is not enough information about the safety of aprepitant during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if aprepitant passes into breast milk, so discuss breastfeeding with your doctor.

Also Compare — Nearby Drugs

Compare aprepitant with

How to Read This alosetron vs aprepitant Comparison

alosetron is classified in the 5-HT3 Antagonist (IBS-D) drug class, while aprepitant sits within the NK1 Receptor Antagonist (Antiemetic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alosetron has 42 submissions while aprepitant has 8,556. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between alosetron and aprepitant — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.